Skip to content

CUBIST PHARMACEUTICALS INC

CIK 0000912183

← back to feed
Revenue (TTM)
$1.13B
+12.7% YoY Q3 Nov 2014
Net Income (TTM)
—
Q3 Nov 2014
EPS Diluted (TTM)
$0.39
+84.0% YoY Q3 Nov 2014
Gross Margin
71.9%
Q3 Nov 2014
Operating Margin
12.6%
Q3 Nov 2014
Net Margin
—
Q3 Nov 2014
Free Cash Flow (TTM)
$156.98M
Q3 Nov 2014
Cash
$233.69M
Q3 Nov 2014
Total Debt
$1.04B
Q3 Nov 2014
Shares Outstanding
76.3M sh
Q3 Nov 2014

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings